Headaches ( traumatic brain injuries [TBI] are a strong predictor of headaches. PTSD and depression symptoms increase the ...

The waveLINE-003 trial demonstrates the efficacy of zilovertamab vedotin combined with standard therapy, with manageable safety profiles in difficult-to-treat DLBCL patients. ADCs provide logistical ...

Significant treatment options are changing the management of CLL, according to research presented at the ASH Annual Meeting 2025.

Once limited to nonspecific anti-inflammatory therapies, expanding treatment options for atopic dermatitis are allowing therapy to be individualized.

A child who received the world's first personalized CRISPR therapy is now taking his first steps after months in hospital ...